Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis
- PMID: 34295979
- PMCID: PMC8284167
- DOI: 10.5114/ceh.2021.105915
Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis
Abstract
Aim of the study: The study aimed to investigate serum and ascitic fluid D-dimer level in patients with liver cirrhosis with and without ascites and to evaluate the impact of spontaneous bacterial peritonitis (SBP) on circulating serum and ascitic fluid D-dimer levels.
Material and methods: This study was conducted on 60 subjects who were further subdivided into group I comprising 15 patients with liver cirrhosis and no ascites, group II comprising 15 cirrhotic patients with ascites, group III comprising 15 cirrhotic patients with ascites and SBP, and group IV comprising 15 healthy controls. All patients were subjected to full history taking, physical examination, laboratory investigations, and measurement of serum D-dimer in all groups and ascitic fluid D-dimer in groups II and III. The diagnostic performance of serum D-dimer was tested to detect SBP.
Results: Serum D-dimer differed significantly between groups III and IV, whilst no significant differences were detected between the other groups and group IV. Moreover, group III showed a significantly higher level of serum D-dimer. Ascitic fluid D-dimer mean levels showed no statistically significant differences. A statistically significant positive correlation was found between serum D-dimer level and ascitic fluid D-dimer in group III, r = 0.682. Using a sensitivity and specificity level of 80%, a cut-off value (COV) of > 323.2 ng/ml could differentiate between patients with SBP and patients with ascites only.
Conclusions: Serum D-dimer significantly correlated with ascitic fluid D-dimer in patients with SBP, whereas no significant correlation was found in patients with cirrhotic ascites without bacterial infection. D-dimer showed good diagnostic performance for SBP among patients with liver cirrhosis.
Keywords: D-dimer; ascites; liver cirrhosis; spontaneous bacterial peritonitis.
Copyright © 2021 Clinical and Experimental Hepatology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis.Curr Res Transl Med. 2020 Nov;68(4):237-243. doi: 10.1016/j.retram.2020.03.001. Epub 2020 Jul 1. Curr Res Transl Med. 2020. PMID: 32620468
-
Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites.J Natl Med Assoc. 2005 Feb;97(2):276-80. J Natl Med Assoc. 2005. PMID: 15712792 Free PMC article.
-
The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patients.Int J Med Sci. 2013 Aug 20;10(10):1367-74. doi: 10.7150/ijms.6014. eCollection 2013. Int J Med Sci. 2013. PMID: 23983598 Free PMC article.
-
Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites?Lab Med. 2021 Nov 2;52(6):567-573. doi: 10.1093/labmed/lmab019. Lab Med. 2021. PMID: 33939819
-
Predictive and Prognostic Value of Ascitic Fluid Mannose Binding Lectin in Patients with Spontaneous Bacterial Peritonitis.Antiinflamm Antiallergy Agents Med Chem. 2021;20(2):196-200. doi: 10.2174/1871523019666200617132513. Antiinflamm Antiallergy Agents Med Chem. 2021. PMID: 32552645
Cited by
-
Predictive value of elevated serum D-dimer for short-term prognosis in patients with HBV-related acute-on-chronic liver failure.Exp Ther Med. 2022 May 30;24(1):472. doi: 10.3892/etm.2022.11399. eCollection 2022 Jul. Exp Ther Med. 2022. PMID: 35761810 Free PMC article.
-
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5. BMC Infect Dis. 2025. PMID: 40596896 Free PMC article.
-
A novel laboratory-based nomogram for assessing infection presence risk in acute-on-chronic liver failure patients.Sci Rep. 2023 Oct 8;13(1):16970. doi: 10.1038/s41598-023-44006-9. Sci Rep. 2023. PMID: 37806983 Free PMC article.
-
Analysis of Complications and Risk Factors Other than Bleeding before and after Endoscopic Treatment of Esophagogastric Variceal Bleeding in Patients with Liver Cirrhosis.Can J Gastroenterol Hepatol. 2023 Mar 29;2023:7556408. doi: 10.1155/2023/7556408. eCollection 2023. Can J Gastroenterol Hepatol. 2023. PMID: 37034104 Free PMC article.
References
-
- Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116: 878-885. - PubMed
-
- Senzolo M, Burroughs A. Coagulopathy and clotting disorders. In: Lee SS, Moreau R (Eds.). Cirrhosis: a practical guide to management. John Wiley & Sons Ltd. 2015; 249-260.
-
- Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 2013; 11: 1064-1074. - PubMed
-
- Romanelli R, Cellai A, Lami D, et al. . D-dimer and fibrinolytic activity in patients with decompensated liver cirrhosis. Digest Liver Dis 2015; 47: e33.
LinkOut - more resources
Full Text Sources
Research Materials